Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers.
about
Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Abundant tumor infiltrating ly ...... /HER2-negative breast cancers.
@en
Abundant tumor infiltrating ly ...... /HER2-negative breast cancers.
@nl
type
label
Abundant tumor infiltrating ly ...... /HER2-negative breast cancers.
@en
Abundant tumor infiltrating ly ...... /HER2-negative breast cancers.
@nl
prefLabel
Abundant tumor infiltrating ly ...... /HER2-negative breast cancers.
@en
Abundant tumor infiltrating ly ...... /HER2-negative breast cancers.
@nl
P2093
P2860
P1476
Abundant tumor infiltrating ly ...... /HER2-negative breast cancers.
@en
P2093
Akira I Hida
Kouhei Akazawa
Michiko Imamura
Natsuko Inoue
Seiichi Hirota
Takahiro Watanabe
Yasuo Miyoshi
Yukie Fujimoto
P2860
P2888
P356
10.1007/S10549-017-4575-Z
P407
P577
2017-11-22T00:00:00Z
P6179
1092864331